vs

Side-by-side financial comparison of ACCURAY INC (ARAY) and HIVE Digital Technologies Ltd. (HIVE). Click either name above to swap in a different company.

ACCURAY INC is the larger business by last-quarter revenue ($102.2M vs $93.1M, roughly 1.1× HIVE Digital Technologies Ltd.). ACCURAY INC runs the higher net margin — -13.5% vs -98.1%, a 84.6% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -12.0%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 0.5%).

Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It is the developer of innovative technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, the latest generation TomoTherapy platform. The company is headquartered in Sunnyvale, CA, the United States. The platforms are installed in leading healthcare ...

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

ARAY vs HIVE — Head-to-Head

Bigger by revenue
ARAY
ARAY
1.1× larger
ARAY
$102.2M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+230.6% gap
HIVE
218.6%
-12.0%
ARAY
Higher net margin
ARAY
ARAY
84.6% more per $
ARAY
-13.5%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
0.5%
ARAY

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
ARAY
ARAY
HIVE
HIVE
Revenue
$102.2M
$93.1M
Net Profit
$-13.8M
$-91.3M
Gross Margin
23.5%
-27.1%
Operating Margin
-11.3%
Net Margin
-13.5%
-98.1%
Revenue YoY
-12.0%
218.6%
Net Profit YoY
-642.8%
-234.0%
EPS (diluted)
$-0.11
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARAY
ARAY
HIVE
HIVE
Q4 25
$102.2M
$93.1M
Q3 25
$93.9M
$87.3M
Q2 25
$127.5M
$45.6M
Q1 25
$113.2M
Q4 24
$116.2M
$29.2M
Q3 24
$101.5M
$22.6M
Q2 24
$134.3M
$32.2M
Q1 24
$101.1M
Net Profit
ARAY
ARAY
HIVE
HIVE
Q4 25
$-13.8M
$-91.3M
Q3 25
$-21.7M
$-15.8M
Q2 25
$1.1M
$35.0M
Q1 25
$-1.3M
Q4 24
$2.5M
$68.2M
Q3 24
$-4.0M
$80.0K
Q2 24
$3.4M
$-18.3M
Q1 24
$-6.3M
Gross Margin
ARAY
ARAY
HIVE
HIVE
Q4 25
23.5%
-27.1%
Q3 25
28.3%
4.7%
Q2 25
30.6%
-13.6%
Q1 25
27.9%
Q4 24
36.1%
-43.7%
Q3 24
33.9%
-66.1%
Q2 24
28.6%
-7.4%
Q1 24
28.7%
Operating Margin
ARAY
ARAY
HIVE
HIVE
Q4 25
-11.3%
Q3 25
-12.0%
Q2 25
3.3%
Q1 25
0.9%
Q4 24
4.1%
Q3 24
-2.1%
Q2 24
5.1%
Q1 24
-4.5%
Net Margin
ARAY
ARAY
HIVE
HIVE
Q4 25
-13.5%
-98.1%
Q3 25
-23.1%
-18.1%
Q2 25
0.9%
76.8%
Q1 25
-1.1%
Q4 24
2.2%
233.2%
Q3 24
-3.9%
0.4%
Q2 24
2.5%
-56.7%
Q1 24
-6.3%
EPS (diluted)
ARAY
ARAY
HIVE
HIVE
Q4 25
$-0.11
$-0.38
Q3 25
$-0.18
$-0.07
Q2 25
$0.01
$0.18
Q1 25
$-0.01
Q4 24
$0.02
$0.52
Q3 24
$-0.04
$0.00
Q2 24
$0.03
$-0.17
Q1 24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARAY
ARAY
HIVE
HIVE
Cash + ST InvestmentsLiquidity on hand
$41.3M
Total DebtLower is stronger
$135.9M
Stockholders' EquityBook value
$53.4M
$559.3M
Total Assets
$448.0M
$624.0M
Debt / EquityLower = less leverage
2.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARAY
ARAY
HIVE
HIVE
Q4 25
$41.3M
Q3 25
$63.3M
Q2 25
$57.4M
Q1 25
$77.8M
Q4 24
$62.6M
$40.5M
Q3 24
$59.2M
$31.7M
Q2 24
$68.6M
Q1 24
$60.5M
Total Debt
ARAY
ARAY
HIVE
HIVE
Q4 25
$135.9M
Q3 25
$140.2M
Q2 25
$136.5M
Q1 25
$173.8M
Q4 24
$175.5M
Q3 24
$170.2M
Q2 24
$172.2M
Q1 24
$173.5M
Stockholders' Equity
ARAY
ARAY
HIVE
HIVE
Q4 25
$53.4M
$559.3M
Q3 25
$61.9M
$624.6M
Q2 25
$81.2M
$560.5M
Q1 25
$49.6M
Q4 24
$47.9M
$430.9M
Q3 24
$45.2M
$275.5M
Q2 24
$45.1M
$268.6M
Q1 24
$41.1M
Total Assets
ARAY
ARAY
HIVE
HIVE
Q4 25
$448.0M
$624.0M
Q3 25
$456.8M
$693.0M
Q2 25
$470.2M
$628.7M
Q1 25
$484.3M
Q4 24
$478.4M
$478.6M
Q3 24
$473.1M
$334.7M
Q2 24
$468.6M
Q1 24
$462.5M
Debt / Equity
ARAY
ARAY
HIVE
HIVE
Q4 25
2.54×
Q3 25
2.27×
Q2 25
1.68×
Q1 25
3.50×
Q4 24
3.66×
Q3 24
3.76×
Q2 24
3.82×
Q1 24
4.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARAY
ARAY
HIVE
HIVE
Operating Cash FlowLast quarter
$-16.0M
$46.0M
Free Cash FlowOCF − Capex
$-19.0M
FCF MarginFCF / Revenue
-18.6%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARAY
ARAY
HIVE
HIVE
Q4 25
$-16.0M
$46.0M
Q3 25
$12.2M
$-10.6M
Q2 25
$-9.7M
$10.2M
Q1 25
$18.1M
Q4 24
$1.8M
$-28.5M
Q3 24
$-7.3M
$-2.2M
Q2 24
$9.9M
$-4.4M
Q1 24
$-8.1M
Free Cash Flow
ARAY
ARAY
HIVE
HIVE
Q4 25
$-19.0M
Q3 25
$10.3M
Q2 25
$-11.0M
Q1 25
$17.1M
Q4 24
$927.0K
$-55.5M
Q3 24
$-8.4M
$-34.7M
Q2 24
$9.4M
Q1 24
$-8.9M
FCF Margin
ARAY
ARAY
HIVE
HIVE
Q4 25
-18.6%
Q3 25
10.9%
Q2 25
-8.6%
Q1 25
15.1%
Q4 24
0.8%
-189.9%
Q3 24
-8.3%
-153.4%
Q2 24
7.0%
Q1 24
-8.8%
Capex Intensity
ARAY
ARAY
HIVE
HIVE
Q4 25
3.0%
Q3 25
2.0%
Q2 25
1.0%
Q1 25
0.8%
Q4 24
0.8%
92.5%
Q3 24
1.1%
143.9%
Q2 24
0.3%
Q1 24
0.8%
Cash Conversion
ARAY
ARAY
HIVE
HIVE
Q4 25
Q3 25
Q2 25
-8.64×
0.29×
Q1 25
Q4 24
0.71×
-0.42×
Q3 24
-26.94×
Q2 24
2.92×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARAY
ARAY

Services$57.2M56%
Products$45.0M44%

HIVE
HIVE

Segment breakdown not available.

Related Comparisons